Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: A randomized phase III trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: A randomized phase III trial

Published:2021-03 Issue:3 Volume:74 Page:603-612
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Kim Tae Hyun^ORCID,Koh Young Hwan,Kim Bo Hyun,Kim Min Ju,Lee Ju Hee^ORCID,Park Boram^ORCID,Park Joong-Won^ORCID

Funder

National Cancer Center

Publisher

Elsevier BV

Subject

Hepatology

Reference40 articles.

1. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the Global Burden of Disease study 2015;Akinyemiju;JAMA Oncol,2017

2. Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study;Park;Liver Int,2015

3. EASL clinical practice guidelines: management of hepatocellular carcinoma;J Hepatol,2018

4. 2018 Korean Liver Cancer Association-National Cancer Center Korea practice guidelines for the management of hepatocellular carcinoma;Gut and liver,2019

5. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases;Marrero;Hepatology,2018

Cited by 136 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Evolving Landscape of Stereotactic Body Radiation Therapy in Hepatocellular Carcinoma;Journal of Clinical and Experimental Hepatology;2025-01

2. Stereotactic body radiotherapy is an alternative to radiofrequency ablation for single HCC ≤5.0 cm;JHEP Reports;2024-10

3. Oncologic outcomes and rates of hepatotoxicity following stereotactic body radiotherapy for hepatocellular carcinoma;Hepatoma Research;2024-09-07

4. Expanding Indications for Liver Transplantation in the Treatment of Hepatocellular Carcinoma;Current Oncology;2024-08-20

5. Evaluation and Management of Unresectable Hepatocellular Carcinoma: Multidisciplinary Indian Consensus Statements from a Delphi Panel;South Asian Journal of Cancer;2024-07-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3